Skip Navigation

Admissions

Admissions Blog

Date: May 2019

Congratulations to the Johns Hopkins Bloomberg School of Public Health’s Class of 2019! This year’s graduates come from 44 U.S. states and territories, and the District of Columbia. Including the U.S., 50 countries are represented in the class.

Today, Admissions Services will close at 12 noon to assist with the Bloomberg School’s Convocation Ceremony. The office will reopen on Wednesday, May 22 at 8 a.m.

US Map World Map

Key

Office Staff at Our Daily Bread

Last week, Admissions Services was closed for a day. Each year, as an office, we set aside the day to volunteer in the Baltimore community. We always try to work with a different organization to help connect each of us to organizations if we want to continue volunteering at that location. For example, I currently volunteer at Commodore John Rogers Elementary, which is where we did our day of service last year (I blogged about it too).

This year, we spent the day at Our Daily Bread preparing and serving lunch. The Our Daily Bread Hot Meal program is restaurant style. The guests come in and are given an option between meals and are served by volunteers.

As an office, we helped prepare the peanut butter and jelly sandwiches for the vegetarian option, wash and cut fresh strawberries and peel and cut hard boiled eggs. Once the guests arrived for the main meal of the day, we worked with other volunteers to plate, serve and wash dishes. Overall, we had a great time together and I look forward to volunteering there in the future.

Lyme disease’s history is riddled with mysteries, but new research from the Johns Hopkins Bloomberg School of Public Health might have uncovered a new treatment to prevent lifelong symptoms of the disease.

Researchers found a variant of Lyme disease that is slow growing and may be the cause of the 10-20 percent of patients that experience lifelong symptoms from the disease. This variant is resistant to the standard single antibiotic treatment of Lyme disease. However, in test tubes and mice, the researchers found a three-antibiotic cocktail eradicated the Lyme bacteria.

“There is a lot of excitement in the field, because we now have not only a plausible explanation but also a potential solution for patients who suffer from persistent Lyme disease symptoms despite standard single-antibiotic treatment,” says study senior author Ying Zhang, MD, PhD, professor in the Department of Molecular Microbiology and Immunology at the Bloomberg School.

“A lot of physicians have been wanting to do clinical trials of antibiotic combinations in post- treatment Lyme disease syndrome patients, and now we have results in animals that support the idea of such trials,” Zhang says.

Zhang and his colleagues are making plans for their own trials and hope that some of their results will help not just Lyme patients, but other patients with persistent diseases.

The research was published in the March 28 issue of Discovery Medicine. More information can also be found in the Bloomberg School’s press release.